Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Flam

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer|April 3, 1999
Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology GroupS R Bonin, T F Pajak, A H Russell, et al.
Cancer|April 15, 1983
Definitive nonsurgical therapy of epithelial malignancies of the anal canal. A report of 12 casesM S Flam, M John, L J Lovalvo, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II studyT L Phillips, V A Levin, D K Ahn, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer|April 3, 1999
Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology GroupS R Bonin, T F Pajak, A H Russell, et al.
Cancer|April 15, 1983
Definitive nonsurgical therapy of epithelial malignancies of the anal canal. A report of 12 casesM S Flam, M John, L J Lovalvo, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II studyT L Phillips, V A Levin, D K Ahn, et al.
Pageof 3